The Newcastle upon Tyne Hospitals NHS Foundation Trust

Newcastle NEI 4LP

1 studies enrolling now · 7 studies all time

What they study most

Acute Myeloid Leukemia, Adult, Colorectal Cancer, Colorectal Cancer Metastatic, Gastric Cancer, Idiopathic Pulmonary Fibrosis, Non-small Cell Lung Cancer, Pancreatic Cancer, Pulmonary Arterial Hypertension, Renal Cell Carcinoma, Thyroid Eye Disease, Thyroid Eye Disease (TED), Triple Negative Breast Cancer

Studies at this site

• Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML — Recruiting now
• A Safety and Tolerability Study of VRDN-003 in Participants With Thyroid Eye Disease (TED) — Running, not enrolling
• An Efficacy, Safety, and Tolerability Study of Veligrotug (VRDN-001), in Participants With Chronic Thyroid Eye Disease (TED) (THRIVE-2) — Completed
• A Study of AV-101 (Dry Powder Inhaled Imatinib) in Patients With Pulmonary Arterial Hypertension (PAH) — Stopped early
• GEN1029 (HexaBody®-DR5/DR5) Safety Trial in Patients With Malignant Solid Tumors — Stopped early
• A Clinical Study to Test How Effective and Safe GLPG1690 is for Subjects With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard of Care — Stopped early
• Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer — Completed